Clinical Study

A Trial Of Transplanting Hepatitis C Kidneys Into Hepatitis C Negative Kidney Recipients

Posted Date: Jan 5, 2021

  • Investigator: Rita Alloway
  • Specialties:
  • Type of Study: Drug

This study will include adult kidney transplant candidates without Hepatitis C (HCV) infection on the transplant waiting list who will consent to kidney transplantation from a deceased donor infected with HCV, followed by treatment with a direct acting antiviral. The HCV cure rate will be determined along with patient survival, graft survival, rate of CMV disease and pathologic findings of transplanted kidneys.


Patients Awaiting A Kidney Transplant


Hepatitis C, Kidney Transplant

For More Information:

Rita R. Alloway

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.